Women's heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s, rather than well after menopause as is now the practice.
This is according to American researchers who published a study on this, as well as presented their findings at the European Society of Cardiology annual meeting in London, United Kingdom, last week (Aug 30 - Sept 2, 2024).
